An upcoming summit hosted by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in conjunction with the Food and Drug Administration (FDA) is set to focus on using patient-preference data in regulatory decision making for medical devices.
The summit, “Using Patient-Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond,” is set for March 31 at the FDA White Oak Campus in Silver Spring, Maryland.
“Patient-preference information is increasingly being used in regulatory decision making for medical devices,” ISPOR says in a press release. “The ISPOR-FDA Summit will provide a forum to engage key stakeholders … to discuss and explore the role, challenges, and opportunities of using patient-preference information across the healthcare ecosystem.”
To learn more about this event, click here.
